Eyebright Medical Technology Beijing Co Ltd (688050) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Eyebright Medical Technology Beijing Co Ltd (688050) has a cash flow conversion efficiency ratio of 0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥76.92 Million ≈ $11.26 Million USD) by net assets (CN¥3.01 Billion ≈ $440.17 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Eyebright Medical Technology Beijing Co balance sheet independence to measure how much of total assets are equity-financed.
Eyebright Medical Technology Beijing Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Eyebright Medical Technology Beijing Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Eyebright Medical Technology Beijing Co cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Eyebright Medical Technology Beijing Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Eyebright Medical Technology Beijing Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
China Resources Boya Bio pharmaceutical Group Co Ltd
SHE:300294
|
0.005x |
|
Guangzhou Restaurants Group Co
SHG:603043
|
0.243x |
|
Shanghai STEP Electric Corp
SHE:002527
|
0.009x |
|
Perella Weinberg Partners
NASDAQ:PWP
|
0.295x |
|
Cascades Inc.
TO:CAS
|
0.010x |
|
Longwell Co
TWO:6290
|
0.037x |
|
Chengdu RML Technology Co. Ltd.
SHE:301050
|
N/A |
|
Godrej Agrovet Limited
NSE:GODREJAGRO
|
0.153x |
Annual Cash Flow Conversion Efficiency for Eyebright Medical Technology Beijing Co Ltd (2016–2025)
The table below shows the annual cash flow conversion efficiency of Eyebright Medical Technology Beijing Co Ltd from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see market cap of Eyebright Medical Technology Beijing Co .
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥2.97 Billion ≈ $434.64 Million |
CN¥369.15 Million ≈ $54.02 Million |
0.124x | -5.86% |
| 2024-12-31 | CN¥2.63 Billion ≈ $385.47 Million |
CN¥347.75 Million ≈ $50.89 Million |
0.132x | +37.45% |
| 2023-12-31 | CN¥2.36 Billion ≈ $344.75 Million |
CN¥226.27 Million ≈ $33.11 Million |
0.096x | -26.27% |
| 2022-12-31 | CN¥1.92 Billion ≈ $280.98 Million |
CN¥250.13 Million ≈ $36.60 Million |
0.130x | +3.37% |
| 2021-12-31 | CN¥1.74 Billion ≈ $254.64 Million |
CN¥219.30 Million ≈ $32.09 Million |
0.126x | +58.11% |
| 2020-12-31 | CN¥1.55 Billion ≈ $226.47 Million |
CN¥123.35 Million ≈ $18.05 Million |
0.080x | +2.21% |
| 2019-12-31 | CN¥647.52 Million ≈ $94.75 Million |
CN¥50.49 Million ≈ $7.39 Million |
0.078x | +35.73% |
| 2018-12-31 | CN¥553.87 Million ≈ $81.05 Million |
CN¥31.82 Million ≈ $4.66 Million |
0.057x | +174.70% |
| 2017-12-31 | CN¥198.44 Million ≈ $29.04 Million |
CN¥4.15 Million ≈ $607.32K |
0.021x | +216.46% |
| 2016-12-31 | CN¥187.52 Million ≈ $27.44 Million |
CN¥-3.37 Million ≈ $-492.75K |
-0.018x | -- |
About Eyebright Medical Technology Beijing Co Ltd
Eyebright Medical Technology (Beijing) Co., Ltd. engages in development, production, and commercialization of ophthalmic medical devices in China and internationally. The company offers intraocular, trimmers, capsular tension ring, defocus lense, orthokeratology, and contact lenses in the areas of surgical treatment, myopia management, and consumer vision care. It also provides solutions for opht… Read more